Key facts
- Nimbus Health’s last known valuation is $48.5M (Jun 2025).
- It has raised $16.8M; the latest was Seed Round ($12.0M) in Jun 2025.
- Notable investors include General Catalyst, 8VC, 2048 Ventures, Four Acres Capital, StoryHouse Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Nimbus Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Nimbus Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nimbus Health
Operator of a technology-enabled clinic intended to deliver personalized care through at-home diagnostics and virtual consultations. The company offers AI-guided health coaching, clinician-led treatment planning, and direct-to-door prescription services to keep lung conditions under control by exacerbation detection and treatment, pulmonary rehabilitation, medication adherence monitoring, and support, enabling men and women seeking hormone, weight, and hair-related therapies to manage their health conveniently and privately.
- Sector
- Healthcare
- HQ
- Sheridan, WY, United States
- Founded
- 2022
- Employees
- 10
- Website
- nimbushealth.com/
- Ownership
- Privately Held (backing)
Nimbus Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nimbus Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nimbus Health in its N-PORT filings yet. We sweep new filings monthly.